Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilip Moonka

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|August 8, 2014
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationShunji Nagai, Atsushi Yoshida, Marcelo Facciuto, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2021
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30Toshihiro Kitajima, Dilip Moonka, Sirisha Yeddula, et al.
Clinical Transplantation|February 20, 2020
Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registryToshihiro Kitajima, Dilip Moonka, Siri Yeddula, et al.
Clinical Transplantation|March 25, 2014
Beyond survival: how well do transplanted livers work? A preliminary comparison of standard-risk, high-risk, and living donor recipientsLisa R Miller-Matero, Anne Eshelman, Daniel Paulson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2019
Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other EtiologiesShunji Nagai, Kelly Collins, Lucy C Chau, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantationShunji Nagai, Atsushi Yoshida, Keisuke Kohno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Risk for renal cell carcinoma in chronic hepatitis C infectionStuart C Gordon, Dilip Moonka, Kimberly A Brown, et al.
Transplantation Direct|February 21, 2022
Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver FailureToshihiro Kitajima, Yasutaka Kuno, Tommy Ivanics, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2020
A Share 21 model in liver transplantation: Impact on waitlist outcomesShunji Nagai, Lucy C Chau, Toshihiro Kitajima, et al.
Clinical Transplantation|February 8, 2012
Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted?Mazen El Atrache, Marwan Abouljoud, Saurabh Sharma, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|August 8, 2014
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationShunji Nagai, Atsushi Yoshida, Marcelo Facciuto, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2021
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30Toshihiro Kitajima, Dilip Moonka, Sirisha Yeddula, et al.
Clinical Transplantation|February 20, 2020
Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registryToshihiro Kitajima, Dilip Moonka, Siri Yeddula, et al.
Clinical Transplantation|March 25, 2014
Beyond survival: how well do transplanted livers work? A preliminary comparison of standard-risk, high-risk, and living donor recipientsLisa R Miller-Matero, Anne Eshelman, Daniel Paulson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 21, 2019
Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other EtiologiesShunji Nagai, Kelly Collins, Lucy C Chau, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantationShunji Nagai, Atsushi Yoshida, Keisuke Kohno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Risk for renal cell carcinoma in chronic hepatitis C infectionStuart C Gordon, Dilip Moonka, Kimberly A Brown, et al.
Transplantation Direct|February 21, 2022
Improved Survival With Higher-risk Donor Grafts in Liver Transplant With Acute-on-chronic Liver FailureToshihiro Kitajima, Yasutaka Kuno, Tommy Ivanics, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 11, 2020
A Share 21 model in liver transplantation: Impact on waitlist outcomesShunji Nagai, Lucy C Chau, Toshihiro Kitajima, et al.
Clinical Transplantation|February 8, 2012
Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted?Mazen El Atrache, Marwan Abouljoud, Saurabh Sharma, et al.
Pageof 6